Alethia Young
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $55K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 6SEC | BCYCBicycle Therapeutics PLC | Sell Plan | 3,28991,415 held (−3%) | $6.80 | $22K | -42.8% |
| Jan 6SEC | BCYCBicycle Therapeutics PLC | Sell Plan | 2,45688,959 held (−3%) | $6.45 | $16K | -39.7% |
| Jan 6SEC | BCYCBicycle Therapeutics PLC | Sell Plan | 1,87887,081 held (−2%) | $6.54 | $12K | -40.5% |
| Oct 6SEC | BCYCBicycle Therapeutics PLC | Sell Plan | 21744,969 held (−0%) | $8.40 | $2K | -53.7% |
| Oct 6SEC | BCYCBicycle Therapeutics PLC | Sell Plan | 26544,704 held (−1%) | $8.61 | $2K | -54.8% |
- Sell
CFO Alethia Young sold $22K of BCYC at $6.80 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Alethia Young sold $16K of BCYC at $6.45 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Alethia Young sold $12K of BCYC at $6.54 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Alethia Young sold $2K of BCYC at $8.40 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Alethia Young sold $2K of BCYC at $8.61 — pre-scheduled 10b5-1 plan sale.